11-Ethyl-17-ethynyl-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol

ID: ALA1627851

Chembl Id: CHEMBL1627851

PubChem CID: 53318534

Max Phase: Preclinical

Molecular Formula: C22H28O2

Molecular Weight: 324.46

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3C(CC)C[C@@]21C

Standard InChI:  InChI=1S/C22H28O2/c1-4-14-13-21(3)19(10-11-22(21,24)5-2)18-8-6-15-12-16(23)7-9-17(15)20(14)18/h2,7,9,12,14,18-20,23-24H,4,6,8,10-11,13H2,1,3H3/t14?,18-,19-,20+,21-,22-/m0/s1

Standard InChI Key:  XDNAXLLZXDEEDC-INEWXLMMSA-N

Associated Targets(Human)

SHBG Tchem Testis-specific androgen-binding protein (320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Esr1 Estrogen receptor (1901 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Afp Alpha-fetoglobulin (20 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 324.46Molecular Weight (Monoisotopic): 324.2089AlogP: 4.25#Rotatable Bonds: 1
Polar Surface Area: 40.46Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 10.31CX Basic pKa: CX LogP: 4.63CX LogD: 4.63
Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.76Np Likeness Score: 1.64

References

1. VanBrocklin HF, Carlson KE, Katzenellenbogen JA, Welch MJ..  (1993)  16 beta-([18F]fluoro)estrogens: systematic investigation of a new series of fluorine-18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors.,  36  (11): [PMID:7684451] [10.1021/jm00063a012]

Source